We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+6.52%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$138M
AUM Growth
–
Cap. Flow
+$63.4M
Cap. Flow %
45.95%
Top 10 Hldgs %
47.95%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$4.38M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.25M
3
AZN icon
AstraZeneca
AZN
+$4.19M
4
DGX icon
Quest Diagnostics
DGX
+$4M
5
ARAY icon
Accuray
ARAY
+$3.42M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 60.07%
2 Healthcare 39.54%
3 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
51
DELISTED
Zogenix, Inc.
ZGNX
$473K 0.34%
+34,542
New +$442K
VIRX
52
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$432K 0.31%
+396
New +$441K
ARNA
53
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$385K 0.28%
+5,000
New +$408K
AORT icon
54
CALL
Artivion
AORT
$1.3B
$250K 0.18%
+39,900
New +$244K
TCRT icon
55
Alaunos Therapeutics
TCRT
$4.22M
$211K 0.15%
+667
New +$185K
ANAC
56
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$211K 0.15%
+37,730
New +$228K
1 2
3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Healthcare Value Capital, which disclosed 56 positions worth $138M. Its ten largest holdings account for 48% of the portfolio.

Its largest position is AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, followed by Healthcare and Industrials.

  • Healthcare Value Capital's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 274,481 shares worth $4.57M.
  • Healthcare Value Capital's ten largest holdings make up 48% of its $138M portfolio in Q2 2013.
  • Healthcare Value Capital disclosed 56 positions in Q2 2013, its first 13F filing on record.

Based on Healthcare Value Capital's 13F filing for Q2 2013, filed 8 Aug 2013.